2Brownlee M.Biochemistry and molecular cell biology of diabetic complications.Nature,2001; 414:813 ～ 820
3Jensen LJ,Ostergaard J,Flyvbjerg A.AGE-RAGE and AGE Crosslink interaction:important players in the pathogenesis of diabetic kidney disease.Horm Metab Res,2005 Apr; 37 (Suppl 1):26 ～ 34
9Alsaad KO,Herzenberg AM.Distinguishing diabetic nephropathy from other causes of glomerulosclerosis:an update.J Clin Pathol,2007 Jan; 60(1):18 ～ 26
10Fogarty DG,Rich SS,Hanna L,et al.Urinary albumin excretion in families with type 2 diabetes is heritable and genetically correlated to blood pressure.Kidney Int,2000; 57:250～257
2Adler SG, Pahl M, Seldin MF.Deciphering diabetic nephropathy: progress using genetic strategies.Curr Opin Nephrol Hypertens,2000,9:99-106.
3Lansang MC, Hollenberg NK.Renal perfusion and the renal hemodynamic response to blocking the renin system in diabetes: are the forces leading to vasodilation and vasoconstriction linked?Diabetes,2002,51:2025-2028.
4Volker V, Roland CB, Scott T, et al. Glomerular hyperfiltration and the salt paradox in rarly type 1 diabetes mellitus: a tubulo-centric view. J Am Soc Nephrol, 2003,14:530-537.
5Sheetz MJ, King GL.Molecular understanding of hyperglycemia's adverse effects for diabetic complications.JAMA,2002,288:2579-2588.
6Brownlee M. Biochemistry and molecular cell biology of diabetic complications.Nature,2001,414:813-820.
7Forbes JM, Cooper ME, Thallas V, et al. Reduction of the accumulation of advanced glycation end products by ACE inhibition in experimental diabetic nephropathy.Diabetes,2002,51:3274-3282.
8Evans JL, Goldfine ID, Maddux BA,et al. Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes. Endocr Rev, 2002,23:599-622.
9White KE, Bilous RW, Marshall SM, et al. Podocyte number in normotensive type 1 diabetic patients with albuminuria.Diabetes,2002,51:3083-3089.
10Batlle D. Clinical and cellular markers of diabetic nephropathy.Kidney Int,2003,63:2319-2330.
4Bhatti F, Mankhey RW, Asico L, et al. Mechanisms of antioxidant and prooxidant effects of alpha-lipoic acid in the diabetic and nondiabetic kindney [J]. Kidney Int, 2005, 67(4): 1371-1380.
